On March 28, 2026, a distinguished delegation comprising former President Wang Jianguo of Beijing Aerospace General Hospital, former Director Liu Xuemei of the Ministry of Industry and Information Technology (MIIT), and Vice President Cheng Shuwei of the Biotherapy Branch of the China Health Management Association, along with other leading experts, visited Fanghua International Holding Group for an inspection and research mission. Chairman Yang Zexin, accompanied by the Group's core executive team, extended a warm and comprehensive reception to the delegation. The two parties engaged in deep and productive exchanges on critical topics such as technological innovation in the health industry, commercialization of scientific research achievements, implementation of New Quality Military Innovation projects, and the high‑quality advancement of the silver economy.
During the symposium, Chairman Yang Zexin provided the visiting leaders and experts with a comprehensive overview of Fanghua International Holding Group's 20+ years of technical expertise and R&D achievements in the field of life and health functional optics. He further elaborated on the Group's development strategy and practical roadmap, which centers on its proprietary photonic quantum technology. This strategy anchors itself in the national "Healthy China 2030" initiative, while being fully aligned with three key national policies – military‑civilian integration, rural revitalization, and the silver economy – with the goal of establishing a comprehensive, full‑chain health ecosystem.
Mr. Yu Zhenxing, General Manager of Fanghua International Holding Group, gave a comprehensive presentation to the distinguished leaders and experts, systematically addressing the Group's four core pillars: corporate culture, its full product portfolio, innovative scientific and technological achievements, and New Quality Military Innovation projects. For each pillar, he elaborated on the operating models, core technological advantages, national market presence, and social value creation. The presentation offered a holistic view of the Group's full‑industry‑chain deployment and its formidable competitiveness across the three key national policy‑driven sectors.
Upon the conclusion of the inspection and exchange visit, Fanghua International Holding Group hosted a strategic cooperation signing ceremony in a grand and formal setting. Chairman Yang Zexin, on behalf of the Group, separately signed strategic cooperation agreements with former President Wang Jianguo of Beijing Aerospace General Hospital, former Director Liu Xuemei of the Ministry of Industry and Information Technology (MIIT), and Vice President Cheng Shuwei of the Biotherapy Branch of the China Health Management Association. The three leading experts were officially appointed as strategic consultants to the Group's New Quality Military Innovation projects, thereby formalizing a long‑standing, deep‑level strategic partnership between the Group and these distinguished individuals, and laying a solid foundation for future collaborative endeavors.
This signing represents a significant milestone for Fanghua International in its commitment to advancing the Healthy China strategy and deepening its nationwide industrial presence. It also marks a pivotal step in the Group's efforts to join forces with authoritative experts and drive high‑quality development across the industry. Leveraging this strategic partnership as a catalyst, the Group will continue to focus on R&D in photonic quantum core technology, accelerate the commercialization of innovative scientific achievements, and further advance its New Quality Military Innovation projects. In parallel, it will move forward at full speed with the construction of six major industrial bases and the comprehensive deployment of military‑innovation community health service stations across the country.
We earnestly look forward to forging partnerships with more industry peers who share a strong sense of social responsibility. Together, we aim to set a national standard of excellence in the health industry, unleash the full potential of China's silver economy through high‑quality development, and remain steadfast in our commitment to creating enduring value for the health and well‑being of the nation. In doing so, we are confident that we will collectively write a new and glorious chapter in the industry's ongoing evolution.